


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+1.44%
+5.98%
-13.61%
-15.65%
SNDX
Syndax Pharmaceutica
$20.75
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
SNDX Price Performance
$20.59 (+0.78%)
$19.12 (+8.53%)
$15.44 (+34.39%)
$13.1 (+58.40%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
SNDX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SNDX Street Sentiment is extremely bullish and have positive views on the near-term outlook
SNDX has Low risk level
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Feb 14, 2026
Price Target Raised
Buy
BofA
Nov 28, 2025
Price Target Raised
Overweight
Barclays
Nov 25, 2025
Reiterate
Overweight
Barclays
Nov 13, 2025
Reiterate
Overweight
JP Morgan
Nov 05, 2025
Reiterate
Buy
UBS
What is SNDX current stock price?
What are SNDX stock strengths?
What is SNDX Risk Level?
What is SNDX market cap and volume?
What is SNDX current Stock IQ?
Should I buy SNDX stock right now?
Is SNDX a Strong Buy right now?
What does a 'Strong Buy' rating mean for SNDX?
What does a 'Strong Sell' rating mean for SNDX?
What factors influence SNDX's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
SNDX
Syndax Pharmaceutica
Current Price
$20.75

SNDX Price Performance
$20.59 (+0.78%)
$19.12 (+8.53%)
$15.44 (+34.39%)
$13.1 (+58.40%)
SNDX Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
SNDX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SNDX Street Sentiment is extremely bullish and have positive views on the near-term outlook
SNDX has Low risk level
Average key support and resistance price levels
Overall Wall Street Rating
SNDX Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
SNDX Latest Analysis
Syndax Pharmaceuticals Early Launch Success Signals Continued Growth Into 2026.
Thu Feb 12, 2026
Syndax Announces Participation at the 2026 Guggenheim Emerging Outlook: Biotech Summit. ) a commercial-stage biopharmaceutical company advancing innovative cancer therapies today announced that Michael A. Metzger Chief Executive Officer will participate in a fireside chat at the 2026 Guggenheim Emerging Outlook: Biotech Summit on Thursday February 12 2026 at 12:30 p.m. ET.
Thu Feb 5, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
SNDX Stock trends
SNDX Stock performance
SNDX Stock analysis
SNDX investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.